Nicholas Ede
Chief Technology Officer
Medicine
Imugene Ltd
Australia
Biography
Dr Ede has a record of successfully evolving research concepts to commercial products and processes. Currently at Imugene Ltd, he has initiated and completed a full preclinical and CMC program (IB, IMPD, Protocol submission) culminating in regulatory approval in three countries (HK, TW and TH) to commence a Phase Ib trial in gastric cancer. He has over 25 years experience in drug discovery and international business development gained at Chiron Corporation - now Novartis (VP Chemistry), EqiTX Ltd (COO), Mimotopes Pty Ltd (CEO), Adistem Ltd (CEO) and Consegna (now Rhinomed) Ltd (CTO). He holds a PhD from Monash University and Grad. Cert. in Innovation from Melbourne Business School, and has published over 50 scientific papers and patents.
Research Interest
Clinical Research Healthcare Management ,EMR ,Healthcare Information Technology ,Surgery , Physicians ,Medical Imaging ,Radiology ,Digital Imaging ,Managed Care
